Related Experiment Video
Updated: May 18, 2026
08:42
Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
Virus infection-induced bronchial asthma exacerbation
1Department of Advanced Preventive, Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Pulmonary Medicine
|September 12, 2012
Summary
Respiratory virus infections worsen asthma by increasing airway inflammation and mucus. Asthma medications may help reduce viral and inflammatory responses in the airways.
Area of Science:
- Immunology
- Pulmonology
- Virology
Background:
- Respiratory virus infections, including rhinoviruses, influenza, and RSV, are known triggers for asthma exacerbations.
- These exacerbations involve increased airway inflammation, hyperresponsiveness, and mucus production.
- Key inflammatory mediators like interleukins (ILs) and histamine are elevated during these events.
Purpose of the Study:
- To review the pathogenesis of viral infection-induced asthma exacerbations.
- To explore the modulation of virus-induced airway inflammation.
Main Methods:
- Literature review of studies on viral infections and asthma.
- Analysis of inflammatory mediators and cellular responses in the airways.
- Examination of the impact of viral infections on airway epithelial and endothelial barrier function.
Main Results:
- Viral infections lead to the accumulation of inflammatory cells (neutrophils, lymphocytes, eosinophils) in the airway mucosa.
- Increased production of inflammatory mediators (IL-1, IL-6, IL-8, histamine) by airway cells is observed.
- Impaired interferon response in asthma patients may augment viral replication.
Conclusions:
- Viral infections significantly contribute to asthma exacerbations through complex inflammatory pathways.
- Asthma medications show potential in mitigating viral replication and pro-inflammatory cytokine release.
- Understanding these mechanisms is crucial for developing targeted therapeutic strategies.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...